Related Experiment Video

Updated: May 21, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

[Cystic fibrosis newborn screening: management issues]

A Munck1, M Roussey

  • 1Association Française pour le Dépistage et la Prévention des handicaps de l'Enfant (AFDPHE), 38 rue Cauchy, 75015 Paris, France. anne.munck@rdb.aphp.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|June 12, 2012
PubMed

Insights

Newborn screening for cystic fibrosis (CF) aids early detection but requires improved follow-up care to prevent complications. Research is crucial for refining diagnostic and treatment strategies for infants with CF and atypical CF diagnoses.

Area of Science:

  • Pediatrics
  • Genetics
  • Pulmonology

Context:

  • Newborn screening (NBS) identifies pre-symptomatic cystic fibrosis (CF) cases.
  • Challenges include managing nutritional and pulmonary complications in infants.
  • Atypical CF diagnoses present diagnostic and prognostic dilemmas for clinicians and families.

Purpose:

  • To review current recommendations for follow-up care and treatment of infants identified through NBS.
  • To highlight the need for harmonized practices among CF care specialists.
  • To emphasize the importance of clinical trials for young CF patients.

Summary:

  • NBS facilitates early detection of CF, but effective follow-up is critical to prevent complications.
  • Expert consensus provides guidance on managing infants with confirmed or atypical CF diagnoses.
  • Clinical trials are essential for developing accurate outcome measures for pulmonary function in infants.

Impact:

  • Aims to improve care coordination and outcomes for newborns with CF.
  • Supports the development of evidence-based guidelines for CF management.
  • Encourages clinical research to address knowledge gaps in pediatric CF care.

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment